Literature DB >> 23487461

Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Hangeun Kim1, Keith Meyer, Adrian M Di Bisceglie, Ranjit Ray.   

Abstract

Hepatitis C virus (HCV) proteins inhibit complement component expression, which may attenuate immunity against infection. In this study, we examined whether HCV regulates the membrane attack complex (MAC) via complement component C9. MAC is composed of C5b to C9 (C5b-9) and mediates cell lysis of invaded pathogens. Liver biopsy specimens from chronically HCV-infected patients exhibited a lower level of C9 mRNA expression than liver biopsy specimens from unrelated disease or healthy control human liver RNA. Hepatocytes infected with cell culture-grown HCV or expressing HCV core protein also displayed significant repression of C9 mRNA and protein levels. Promoter analysis suggested that the T cell factor-4 (TCF-4E) transcription factor is responsible for HCV core-mediated C9 promoter regulation. Sera from chronically HCV-infected patients displayed a lower level of C5b-9 and a reduced antimicrobial effect on model organisms compared to unrelated patient sera or sera from healthy volunteers. Together, these results for C9 regulation by HCV core protein coupled with functional impairment of the membrane attack complex underscore HCV-mediated attenuation of immune mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23487461      PMCID: PMC3648158          DOI: 10.1128/JVI.00174-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.

Authors:  L M Lagging; K Meyer; R J Owens; R Ray
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 2.  The membrane attack complex of complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.

Authors:  J R Dankert; A F Esser
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

Review 4.  Membrane attack by complement: the assembly and biology of terminal complement complexes.

Authors:  Cosmin A Tegla; Cornelia Cudrici; Snehal Patel; Richard Trippe; Violeta Rus; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

Review 5.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  The complement system in liver diseases.

Authors:  Xuebin Qin; Bin Gao
Journal:  Cell Mol Immunol       Date:  2006-10       Impact factor: 11.530

7.  Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.

Authors:  E R Podack; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

8.  Activation of the complement system in human nonalcoholic fatty liver disease.

Authors:  Sander S Rensen; Yanti Slaats; Ann Driessen; Carine J Peutz-Kootstra; Jeroen Nijhuis; Rudi Steffensen; Jan Willem Greve; Wim A Buurman
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

9.  Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).

Authors:  Manuel Ramos-Casals; Sandra Muñoz; Francisco Medina; Luis-Javier Jara; José Rosas; Jaime Calvo-Alen; Pilar Brito-Zerón; Xavier Forns; Jose-Maria Sánchez-Tapias
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

10.  Association between hepatitis C infection and other infectious diseases: a case for targeted screening?

Authors:  Hashem B El-Serag; Bhupinderjit Anand; Peter Richardson; Linda Rabeneck
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

View more
  20 in total

1.  Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.

Authors:  Young-Chan Kwon; Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Immunol       Date:  2016-06-29       Impact factor: 5.422

2.  Preferential association of hepatitis C virus with CD19+ B cells is mediated by complement system.

Authors:  Richard Y Wang; Patricia Bare; Valeria De Giorgi; Kentaro Matsuura; Kazi Abdus Salam; Teresa Grandinetti; Cathy Schechterly; Harvey J Alter
Journal:  Hepatology       Date:  2016-10-24       Impact factor: 17.425

Review 3.  Production and pathogenicity of hepatitis C virus core gene products.

Authors:  Hui-Chun Li; Hsin-Chieh Ma; Chee-Hing Yang; Shih-Yen Lo
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 4.  Status of hepatitis C virus vaccination: Recent update.

Authors:  Kouka Saadeldin Abdelwahab; Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

5.  Evaluation of Serum and Gene Expression of Galectin-4, Interleukin-27, and Complement-7 in Hepatitis C Virus-Infected Egyptian Patients.

Authors:  Marwa S Abdel-Tawab; Hanan H Fouad; Dalia A Omran; Aml E Abdou; Shaimaa Mohamed Zaied; Alaa A Mohamed
Journal:  Biomed Res Int       Date:  2020-12-15       Impact factor: 3.411

6.  Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis.

Authors:  Gustavo Ferrín; Manuel Rodríguez-Perálvarez; Patricia Aguilar-Melero; Isidora Ranchal; Camilo Llamoza; Clara I Linares; Sandra González-Rubio; Jordi Muntané; Javier Briceño; Pedro López-Cillero; José Luis Montero-Álvarez; Manuel de la Mata
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

8.  Lipoteichoic Acid from Staphylococcus aureus Activates the Complement System via C3 Induction and CD55 Inhibition.

Authors:  Bong Jun Jung; Hangeun Kim; Kyoung Ok Jang; Seongjae Kim; Dae Kyun Chung
Journal:  Microorganisms       Date:  2021-05-24

Review 9.  The past, present and future of neutralizing antibodies for hepatitis C virus.

Authors:  Jonathan K Ball; Alexander W Tarr; Jane A McKeating
Journal:  Antiviral Res       Date:  2014-02-26       Impact factor: 5.970

Review 10.  Hepatitis C virus infection: establishment of chronicity and liver disease progression.

Authors:  Young-Chan Kwon; Ratna B Ray; Ranjit Ray
Journal:  EXCLI J       Date:  2014-08-27       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.